HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Oct 21, 16:00
HemoGenyx Pharmaceuticals Net Income (Annual) : -12.87M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -12.87M |
| December 31, 2024 | -7.188M |
| December 31, 2023 | -8.324M |
| December 31, 2022 | -4.911M |
| December 31, 2021 | -7.026M |
| Date | Value |
|---|---|
| December 31, 2020 | -2.687M |
| December 31, 2019 | -1.854M |
| December 31, 2018 | -2.059M |
| December 31, 2017 | -3.041M |
| December 31, 2016 | -1.355M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Silence Therapeutics Plc | -88.61M |
| Biodexa Pharmaceuticals Plc | -8.413M |
| NuCana Plc | -38.68M |
| Mereo BioPharma Group Plc | -41.98M |
| Compass Pathways Plc | -288.53M |